Home NDC 0006-4826 VARIVAX
Product NDC 0006-4826
11-digit product format 000064826
Labeler code 0006
Product ID 0006-4826_3825fbed-2fd6-4240-8538-c5a91f07eb31
Type VACCINE
Nonproprietary name Varicella Virus Vaccine Live
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route SUBCUTANEOUS
Labeler Merck Sharp & Dohme LLC
Application BLA103552
Marketing category BLA
Marketing start 1995-03-17
Marketing end 0000-00-00
Substance VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
Active strength 1350 [PFU]/.5mL
Pharmacologic classes Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Vaccines, Attenuated [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0006-4826-00 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0006-4826-00 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0006-4826-00 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0006-4826-00 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0006-4826-00 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0006-4826-00 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0006-4826-00 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0006-4826-00 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0006-4826-00 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0006-4826-00 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0006-4826-00 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0006-4826-00 557ba5c1ecfa…9c80585c8c6e…
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0006-4826-00 VARIVAX 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 47 0006-4826-01 VARIVAX 0.5 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 0.5 47
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN ACTIVE INGREDIENT GPV39ZGD8C VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN ACTIVE MOIETY GPV39ZGD8C VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 ALBUMIN BOVINE INACTIVE INGREDIENT 27432CM55Q VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 EDETIC ACID INACTIVE INGREDIENT 9G34HU7RV0 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 GELATIN INACTIVE INGREDIENT 2G86QN327L VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 MONOSODIUM GLUTAMATE INACTIVE INGREDIENT W81N5U6R6U VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 NEOMYCIN INACTIVE INGREDIENT I16QD7X297 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 POTASSIUM CHLORIDE INACTIVE INGREDIENT 660YQ98I10 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 POTASSIUM PHOSPHATE, MONOBASIC INACTIVE INGREDIENT 4J9FJ0HL51 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 SODIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT GR686LBA74 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 SODIUM PHOSPHATE, MONOBASIC INACTIVE INGREDIENT 3980JIH2SW VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23 SUCROSE INACTIVE INGREDIENT C151H8M554 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] 23
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0006-4826 VARIVAX (VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME LLC] 46 Legacy NDC, 2 package rows 20241116_524cf052-e90e-4595-af0a-608edbe9bd31.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103552 Varivax Varicella Virus Vaccine Live 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0006-4826-00 00006482600 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4826-00) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4826-01) 1995-03-17 0000-00-00 No No Current 0006-4826-01 00006482601 0.5 mL in 1 VIAL, SINGLE-DOSE 0.5 ml Historical